Comparison
17 20 Lyase Deficiency Isolated C3277849 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 17 20 Lyase Deficiency Isolated and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
17 20 Lyase Deficiency Isolated C3277849
A rare enzymatic disorder affecting sex hormone production. Impairs development of sexual characteristics in both males and females. Treatment involves hormone supplementation.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
17 20 Lyase Deficiency Isolated C3277849
0-18
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
17 20 Lyase Deficiency Isolated C3277849
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
17 20 Lyase Deficiency Isolated C3277849
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
17 20 Lyase Deficiency Isolated C3277849
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
17 20 Lyase Deficiency Isolated C3277849
endocrine
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
17 20 Lyase Deficiency Isolated C3277849
endocrine
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
17-20-lyase-deficiency-isolated-C3277849 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 17 20 Lyase Deficiency Isolated C3277849 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Sexual development | May impair sex-hormone-dependent sexual characteristics in males and females. | Not defined by sex-hormone deficiency in the supplied description. | High |
| Developmental features | Not described as a chromosomal developmental syndrome. | Duplication at 11p15.4 may cause varied developmental features. | High |
| Severity pattern | Labeled severe, chronic, with onset from birth through age 18. | Labeled moderate and chronic; onset information is incomplete. | Moderate |
When to favor each condition
Choose 17 20 Lyase Deficiency Isolated C3277849 when
Suspected disorder of sex-hormone production
The source describes an enzymatic endocrine disorder rather than a chromosomal syndrome.
Moderate
Hormone supplementation is being considered
Treatment is described as hormone supplementation, but the regimen requires a clinician.
Moderate
No evidence of an 11p15.4 duplication
An endocrine category is more consistent, although this does not establish the diagnosis.
Low
Choose 11p15 4 Microduplication Syndrome C4749508 when
Testing suggests duplication at 11p15.4
The condition is defined by duplicated chromosome 11 material plus clinical correlation.
High
Varied developmental features need assessment
The source emphasizes variable features and individualized medical assessment.
Moderate
A congenital genetic syndrome fits better
Its category is genetic and congenital rather than an isolated enzyme deficiency.
Moderate
How key tests differ
| Test | 17 20 Lyase Deficiency Isolated C3277849 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Sex-hormone evaluation | May indicate impaired sex-hormone production; no cutoff is established here. | No characteristic hormone result is supplied. | An abnormal hormone result is not itself a diagnosis. |
| Targeted enzyme or gene testing | May support isolated 17,20-lyase deficiency when correlated clinically. | Does not identify an 11p15.4 microduplication. | Testing should match the suspected mechanism and be interpreted by specialists. |
| Chromosomal microarray | Not described as the defining test. | May detect duplication of material at 11p15.4. | A copy-number finding requires genetics and clinical interpretation. |
Prognosis comparison
17 20 Lyase Deficiency Isolated C3277849
- Outcome
- A chronic severe endocrine condition is described, but individual outcomes are not established.
- Factors
- Hormone production, timing of care, and treatment response may matter.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- A chronic moderate congenital condition with variable features is described; outcomes are not established.
- Factors
- Genetic findings, developmental profile, and associated medical needs may matter.
Time frame: Childhood onset is supplied for the enzyme disorder; onset data for the duplication are incomplete.
Severity labels differ, but these sources cannot provide an individualized prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Altered sexual development | Impaired sexual characteristics are described as possible. Not specifically established in the supplied data. Neither phenotype should be assumed without individual evaluation. |
| Developmental differences | Not established by the source description. Varied developmental features may occur. Their range and severity are not quantified here. |
| Ongoing care needs | Hormone supplementation may be required. Individualized developmental and medical follow-up may be needed. Specific complications, doses, and outcomes are not provided. |
Patient education highlights
- HighDifferent rare conditions
One affects sex-hormone production; the other involves duplicated chromosome 11 material and variable development.
- HighSpecialist interpretation
An abnormal test result is not automatically a diagnosis and should be explained by appropriate clinicians.
- MediumIndividualized care
Hormone treatment or developmental support, if used, must be planned individually; no dose is established here.